N-(5-((1-benzylpiperidin-4-yl)methoxy)pyridin-3-yl)-1H-pyrrolo[2,3-b]pyridine-4-carboxamide

ID: ALA4877175

PubChem CID: 155679174

Max Phase: Preclinical

Molecular Formula: C26H27N5O2

Molecular Weight: 441.54

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1cncc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccnc2[nH]ccc12

Standard InChI:  InChI=1S/C26H27N5O2/c32-26(24-7-11-29-25-23(24)6-10-28-25)30-21-14-22(16-27-15-21)33-18-20-8-12-31(13-9-20)17-19-4-2-1-3-5-19/h1-7,10-11,14-16,20H,8-9,12-13,17-18H2,(H,28,29)(H,30,32)

Standard InChI Key:  NTIXCYUTHPYLGJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    8.4683  -19.7128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1867  -20.1286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9032  -19.7179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9125  -18.8889    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1927  -18.4675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4657  -18.8789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6280  -18.4757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6280  -17.6515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3468  -17.2400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3566  -16.4142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6386  -15.9934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9118  -16.4085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9136  -17.2356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3326  -20.1946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0333  -19.7608    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7635  -20.1507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6112  -19.8019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9109  -20.2350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9358  -21.0596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6669  -21.4492    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3641  -21.0138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1851  -19.8447    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4843  -20.2782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7584  -19.8879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7351  -19.0641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0101  -18.6739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3082  -19.1074    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5092  -21.1019    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0614  -20.3218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3385  -19.9399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7519  -20.5094    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1122  -21.2434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9215  -21.1273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 14 15  1  0
 15 16  1  0
 16  1  1  0
 14 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 14  1  0
 18 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 30  1  0
 29 24  1  0
 23 28  2  0
 29 30  2  0
 30 31  1  0
 31 32  1  0
 32 33  2  0
 33 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4877175

    ---

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ache Acetylcholinesterase (12221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 441.54Molecular Weight (Monoisotopic): 441.2165AlogP: 4.50#Rotatable Bonds: 7
Polar Surface Area: 83.14Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.08CX LogP: 3.15CX LogD: 1.47
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.44Np Likeness Score: -1.57

References

1. Jiang X, Liu C, Zou M, Xie H, Lin T, Lyu W, Xu J, Li Y, Feng F, Sun H, Liu W..  (2021)  Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine.,  223  [PMID:34198150] [10.1016/j.ejmech.2021.113663]

Source